Elizabeth M. Turner

发表

Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.

R. Hamatake, Z. Hong, Shawn P. Williams, 2014, Journal of medicinal chemistry.

Pyrazolo[1,5-a]pyridines: synthetic approaches to a novel class of antiherpetics

M. Peel, K. Gudmundsson, F. Boyd, 2003 .

Design of N-Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor

D. J. Price, John Miller, Shawn P. Williams, 2019, Journal of medicinal chemistry.

Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.

Ryan Lauchli, A. Mathis, John F. Miller, 2014, Journal of medicinal chemistry.

Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.

G. A. Freeman, K. Gudmundsson, Zhicheng Wang, 2005, Bioorganic & medicinal chemistry.

Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.

Stephen Jenkinson, S. Jenkinson, P. Sebahar, 2009, Bioorganic & medicinal chemistry letters.

Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infection.

Pamela L. Golden, K. Romines, K. Gudmundsson, 2010, Bioorganic & medicinal chemistry letters.

Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.

S. Jenkinson, K. Gudmundsson, A. Spaltenstein, 2010, Bioorganic & medicinal chemistry letters.

Pyrazolopyridine antiherpetics: SAR of C2' and C7 amine substituents.

J. A. Ray, V. Samano, G. A. Freeman, 2005, Bioorganic & medicinal chemistry.

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

M. Hanlon, E. Furfine, R. Xu, 2006, Bioorganic & medicinal chemistry letters.